26.01.2023

Swissmedic and the UK Veterinary Medicines Directorate agree collaboration on veterinary medicinal products

Raimund Bruhin (Executive Director, Swissmedic) and Gavin Hall (Deputy CEO, Veterinary Medicines Directorate) have signed a Memorandum of Understanding on collaboration in the area of veterinary medicinal products.

26.01.2023

Out-of-Stock – LiDCO Lithiumchlorid 0.15 mmol/ml, Injektionslösung

Befristete Bewilligung zum Vertrieb in tschechischer Aufmachung

23.01.2023

Validity of GMP certificates during the COVID-19 pandemic

Update of the validity period of EMA GMP certificates

20.01.2023

Strategic objectives 2023–2026

The strategy for 2023-2026 was developed with recognised strategy development methods that have demonstrated their usefulness in practice.

20.01.2023

Out-of-Stock – Avalox, Infusionslösung

Befristete Bewilligung zum Vertrieb in österreichischer Aufmachung

19.01.2023

Out-of-Stock – Intratect 10 %, Infusionslösung

Befristete Bewilligung zum Vertrieb in deutscher Aufmachung

18.01.2023

Out-of-Stock – Dotarem, Injektionslösung in 15 ml Fertigspritzen

Befristete Bewilligung zum Vertrieb in US amerikanischer Aufmachung

17.01.2023

Authorities clearly work together

There are products and substances that are difficult to classify – for example, is a product containing hemp or hemp extracts (e.g. a CBD oil) a foodstuff, a therapeutic product, a cosmetic or a chemical? Depending on the answer, different legislation applies and different authorities are responsible. A cross-agency committee of experts with representatives from various cantonal authorities regularly advises on these types of delimitation questions.

In focus

Covid-19-Fokus

COVID-19 Pandemic

Information on the new coronavirus (SARS-CoV-2)
 

Vaccines against COVID-19

Contact for members of the public

Do you have any questions about a particular medicine or a general question about Swissmedic? We’ll be glad to be of assistance. 

Just send an e-mail to anfragen@swissmedic.ch or use our contact form. Thank you.

Direct links


Stay up to date


Reporting undesirable effects and incidents

Medicines


Medical devices

Swiss Public Assessment Report (SwissPAR)

SwissPAR

Public Summary SwissPAR

Featured


Swissmedic video portrait

Swissmedic monitors all therapeutic products on the market in Switzerland. Our independent experts ensure the therapeutic products you and your loved ones need are effective, safe and of the highest quality.

Illegal medicinal products from the Internet

Find out in this video why you should be careful when buying medicinal products online, and what happens if customs officials discover that a consignment addressed to you contains illegally imported medicinal products.

Medizinprodukte

30.05.2022

New medical devices regulations

Information concerning the new EU-Regulations as well as their implementation in Switzerland.

swissmedic-teaser-mep-video1-anim

What are the tasks of Swissmedic in the area of medical devices?

What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.

Medical devices: List of Field Safety Corrective Actions (FSCA) and recalls

Swissmedic monitors all safety measures and recalls for medical devices that are manufactured or marketed in Switzerland.


Swissmedic, Swiss Agency for Therapeutic Products

swissmedic_hauptsitz-hallerstrasse7-bern_03

Swissmedic – for therapeutic products you can trust

Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.

For further information...
https://www.swissmedic.ch/content/swissmedic/en/home.html